Vascular

Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment

Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve replacement (TAVR), has announced completion of enrollment in its … continue reading “Promise for Emboliner™ Embolic Protection Catheter as Safepass 2 Study Completes Enrollment”

Penumbra, Inc., tells us it has seen enrollment of the first patient into a prospective, multi-center U.S. study to evaluate … continue reading “First Patient Enrolled in Coronary Mechanical Thrombus Aspiration Study”

Silk Road Medical Inc. has announced the presentation of real-world data from two studies into the treatment of patients with … continue reading “Carotid Artery Disease Patients do Better with TCAR than Endarterectomy”

One-Year results of SVS TCAR surveillance project will feature

Eximo Medical Ltd. says it has received U.S. FDA 510(k) clearance for its B-Laser™ Atherectomy System for Peripheral Artery Disease (PAD)

Findings confirm the efficacy of the SELUTION sirolimus-coated technology

A first patient has been treated in the EVAS2 IDE Confirmatory Clinical Study of the Nellix® EndoVascular Aneurysm Sealing system.

Endovascular stent graft study promises clinical results later this year

FDA allows study expansion and grants system “Breakthrough Device” status

Updated TCAR data from Silk Road Medical’s ROADSTER 1 and 2 studies presented at VEITH Symposium

Data Presented at 10th Society of Vascular and Interventional Annual Meeting

Seems the promise is realised as new clinical data suggests 3D stent technology outperforms straight comparator

High risk CLI patients avoid amputation at 12 months

Unique catheter-based device for the treatment of advanced PAD/Critical Limb Ischemia

Positive two year data reported from Nellix® EVAS FORWARD IDE Trial

First prospective clinical trial to evaluate endovascular aneurysm repair (EVAR) in women